Show simple item record

dc.contributor.advisorHoelder S
dc.contributor.authorRobertson, C
dc.contributor.editorHoelder, S
dc.date.accessioned2023-05-04T13:20:00Z
dc.date.available2023-05-04T13:20:00Z
dc.date.issued2023-05-04
dc.identifier.citation2023en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5776
dc.description.abstractThe field of bifunctional molecules such as PROTAC, DUBTAC and PhoRC has demonstrated that inducing proximity between two protein complexes is sufficient to redirect post-translational modifications (PTMs), and effect cellular functions. As phosphorylation plays a key role in many cellular functions such as cell growth, signalling and death, the ability to selectively and dose dependently direct phosphorylation of a target protein would be a novel and powerful chemical tool, complementary to kinase inhibitors. Our hypothesis is that rationally designed bifunctional molecules could redirect AMPK to phosphorylate neo-substrates by inducing proximity between a kinase and a target protein. The aim of this work is to show increased levels of phosphorylation of a target protein. Here we showed the development of bifunctional molecules, capable of binding AMP-activated protein kinase (AMPK) and target proteins. We used structural information to identify suitable solvent exposed sites on published AMPK small molecule activators, then designed and synthesised relevant compounds to test their activity. Likewise, a suitable ligand for target proteins was selected and a solvent exposed site identified and validated, and a library of bifunctional compounds synthesised using click chemistry. Testing these compounds in global unbiased phosphoproteomics has shown selective increase in phosphorylation at specific sites, which we sought to confirm with multiple techniques. We anticipate these functional compounds act through ternary complex formation and demonstrate selectivity based on the overall structure of the target protein. Furthermore, we hope that this work may provide a basis for this emerging method of directing phosphorylation.
dc.language.isoengen_US
dc.publisherInstitute of Cancer Research (University Of London)en_US
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserveden_US
dc.titleDesign and synthesis of bifunctional molecules for directing phosphorylationen_US
dc.typeThesis or Dissertation
dcterms.accessRightsPublic
dc.date.updated2023-05-04T13:18:56Z
rioxxterms.versionAOen_US
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserveden_US
rioxxterms.licenseref.startdate2023-05-04
rioxxterms.typeThesisen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 4 (including Analytical Chemistry)
pubs.organisational-group/ICR/Students
pubs.organisational-group/ICR/Students/PhD and MPhil
pubs.organisational-group/ICR/Students/PhD and MPhil/18/19 Starting Cohort
icr.researchteamMedicinal Chemistry 4en_US
dc.contributor.icrauthorRobertson, Charles
uketdterms.institutionInstitute of Cancer Research
uketdterms.qualificationlevelDoctoral
uketdterms.qualificationnamePh.D
icr.provenanceDeposited by Mr Barry Jenkins (impersonating Mr Charlie Robertson) on 2023-05-04. Deposit type is initial. No. of files: 1. Files: Charlie Robertson Thesis.pdf
dc.type.qualificationlevelDoctoral
dc.type.qualificationnamePh.D


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record